Assessment of serosal invasion and criteria for the classification of pathological (p) T4 staging in colorectal carcinoma: Confusions, controversies and criticisms

Cancers

Volumn 3, Issue 1, 2011, Pages 164-181

  Stewart, Colin J R ^a   Hillery, Simon ^a   Platell, Cameron ^a,b   Puppa, Giacomo ^c  

^a ST JOHN OF GOD HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c 'G Fracastoro' City Hospital   (Italy)

Author keywords

Carcinoma; Colorectal; Elastin; Immunohistochemistry; Invasion; Serosa; Stage; T4; TNM

Indexed keywords

CALRETININ; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; ELASTIN; PODOPLANIN; WT1 PROTEIN;

CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CARCINOMA; CYTOLOGY; GASTROINTESTINAL MUCOSA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PERITONEAL FLUID; PERITONEUM METASTASIS; PROGNOSIS; REVIEW; SEROSAL INVASION; TUMOR CLASSIFICATION;

EID: 79953694501     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3010164     Document Type: Review

References (64)

1. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics, 2010. CA Cancer J. Clin. 2010, 60, 277-300.
2. Burt, R.W. Colorectal cancer screening. Curr. Opin. Gastroenterol. 2010, 26, 466-470.
3. Ziobec, I.; Lugli, A. Prognostic and predictive factors in colorectal cancer. J. Clin. Pathol. 2008, 61, 561-569.
4. De Hertogh, G.; Geboes, K.P. Practical and molecular evaluation of colorectal cancer. New roles for the pathologist in the era of targeted therapy. Arch. Pathol. Lab. Med. 2010, 134, 853-863.
5. Horton, J.K.; Tepper, J.E. Staging of colorectal cancer: Past, present, and future. Clin. Colorectal Cancer 2005, 4, 302-312.
6. Sobin, L.H., Gospodarowicz, M.K., Wittekind, C. TNM Classification of Malignant Tumours, 7th ed. Wiley-Blackwell: New York, NY, USA, 2009.
7. Edge, S. B, Byrd D. R, Compton C. C, Fritz A. G, Greene F. L, Trotti A, Eds. AJCC Cancer Staging Manual, 7th edition. Springer: New York, USA, 2009; pp. 143-159.
8. Shepherd, N.A.; Baxter, K.J.; Love, S.B. The prognostic importance of peritoneal involvement in colonic cancer: A prospective evaluation. Gastroenterology 1997, 112, 1096-1102.
9. Sobrero, A.; Kohne, C-H. Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? Lancet Oncol. 2006, 7, 515-517.
10. Figueredo, A.; Coombes, M.E.; Mukherjee, S. Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst. Rev. 2008, 3, CD005390.
11. Marshall, J.L.; Haller, D.G.; de Gramont, A.; Hochster, H.S.; Lenz, H.J.; Ajani, J.A.; Goldberg, R.M. Adjuvant therapy for stage II and III colon cancer: Consensus report of the International Society of Gastrointestinal Oncology. Gastrointest. Cancer Res. 2007, 1, 146-154.
12. Ludeman, L.; Shepherd, N.A. Serosal involvement in gastrointestinal cancer: Its assessment and significance. Histopathology 2005, 47, 123-131.
13. Puppa, G.; Sonzogni, A.; Colombari, R.; Pelosi, G. TNM staging system of colorectal carcinoma. A critical appraisal of challenging issues. Arch. Pathol. Lab. Med. 2010, 134, 837-852.
14. Ludeman, L.; Shepherd, N.A. Macroscopic assessment and microscopic dissection of colorectal cancer resection specimens. Curr. Diagn. Pathol. 2006, 12, 220-230.
15. Hu, M.; Polyak, K. Microenvironmental regulation of cancer development. Curr. Opin. Genet. Dev. 2008, 18, 27-34.
16. Stewart, C.J.R.; Hillery, S.; Havlat, M. Serosal involvement in colorectal carcinoma. Histopathology 2006, 49, 435-437.
17. Newland, R.C.; Dent, O.F.; Chapuis, P.H.; Bokey, L. Survival after curative resection of lymph node negative colorectal carcinoma. Cancer 1995, 76, 564-571.
18. Lennon, A.M.; Mulcahy, H.E.; Hyland, J.M.P.; Lowry, C.; White, A.; Fennelly, D.; Murphy, J.J.; O'Donoghue, D.P.; Sheahan, K. Peritoneal involvement in stage II colon cancer. Am. J. Clin. Pathol. 2003, 119, 108-113.
19. Burdy, G.; Panis, Y.; Alves, A.; Nemeth, J.; Lavergne-Slove, A.; Valleur, P. Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence. Dis. Colon Rectum 2001, 44, 1682-1688.
20. Merkel, S.; Wein, A.; Gunther, K.; Papadopoulos, T.; Hohenberger, W.; Hermanek, P. High-risk groups of patients with stage II colon carcinoma. Cancer 2001, 92, 1435-1443.
21. Petersen, V.C.; Baxter, K.J.; Love, S.B.; Shepherd, N.A. Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut 2002, 51, 65-69.
22. Morris, M.; Platell, C.; de Boer, B.; McCaul, K.; Iacopetta, B. Population-based study of prognostic factors in stage II colonic cancer. Br. J. Surg. 2006, 93, 866-871.
23. Stewart, C.J.R.; Morris, M.; de Boer, B.; Iacopetta, B. Identification of serosal invasion and extramural venous invasion on review of Dukes' stage B colonic carcinomas and correlation with survival. Histopathology 2007, 51, 372-378.
24. Littleford, S.E.; Baird, A.; Rotima, O.; Verbeke, C.S.; Scott, N. Interobserver variation in the reporting of local peritoneal involvement and extramural venous invasion in colonic cancer. Histopathology 2009, 55, 407-413.
25. Shepherd, N.A.; Baxter, K.J.; Love, S.B. Influence of local peritoneal involvement on pelvic recurrence and prognosis in rectal cancer. J. Clin. Pathol. 1995, 48, 849-855.
26. Washington, M.K.; Berlin, J.; Branton. P.A.; Burgart, L.J.; Carter, D.K.; Fitzgibbons, P.L.; Frankel, W.L.; Jessup, J.M.; Kakar, S.; Minsky, B.; et al. Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum. Arch. Pathol. Lab. Med. 2008, 132, 1182-1193.
27. Compton, C.C.; Fielding, P.; Burgart, L.J.; Conley, B.; Cooper, H.S.; Hamilton, S.R.; Hammond, E.H.; Henson, D.E.; Hutter, R.V.P.; Nagle, R.B.; et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch. Pathol. Lab. Med. 2000, 124, 979-994.
28. Compton, C.; Fenoglio-Preiser, C.M.; Pettigrew, N.; Fielding, L.P. American Joint Committee on Cancer Prognostic Factors Consensus Conference. Cancer 2000, 88, 1739-1757.
29. Compton, C.C. Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix. A basis for checklists. Arch. Pathol. Lab. Med. 2000, 124, 1016-1025.
30. Compton, C.C. Colorectal carcinoma: Diagnostic, prognostic, and molecular features. Mod. Pathol. 2003, 16, 376-388.
31. Compton, C. Colon and rectum protocol. Available at: http:/www.cap.org/apps/docs/ cancer_protocols/2005/colonrectum05_pw.doc (accessed on 4 January 4, 2011).
32. Compton, C.C. Key issues in reporting common cancer specimens. Problems in pathologic staging of colon cancer. Arch. Pathol. Lab. Med. 2006, 130, 318-324.
33. Goldstein, N.S. Recent pathology related advances in colorectal adenocarcinomas. Eur. J. Surg. Oncol. 2001, 27, 446-450.
34. Douard, R.; Cugnenc, P.-H.; Wind, P.; Benichou, J. Peritoneal involvement and free tumor cells in peritoneal cavity of patients with colon cancer. Am. J. Clin. Pathol. 2004, 121, 154-155.
35. Swamy, R. Histopathological reporting of pT4 tumour stage in colorectal carcinomas: Dotting the 'i's and crossing the 't's. J. Clin. Pathol. 2010, 63, 110-115.
36. Jass, J.R.; O'Brien, M.J.; Riddell, R.H.; Snover, D.C. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Hum. Pathol. 2007, 38, 537-545.
37. Zeng, Z.; Cohen, A.M.; Hajdu, S.; Sternberg, S.S.; Sigurdson, E.R.; Enker, W. Serosal cytologic study to determine free mesothelial penetration of intraperitoneal colon cancer. Cancer 1992, 70, 737-740.
38. Murphy, P, D.; Hoffman, J.; Karczenski, C.; Gilliland, E.L.; Peel, A.L.; Rosenberg, T.I. Serosal imprint cytology in colonic cancer: A simple staging technique. Int. J. Colorectal Dis. 1994, 9, 96-99.
39. Baskaranathan, S.; Philips, J.; McCredden, P.; Solomon, M.J. Free colorectal cancer cells on the peritoneal surface: Correlation with pathologic variables and survival. Dis. Colon Rectum 2004, 47, 2076-2079.
40. Rekhraj, S.; Aziz, O.; Prabhudesai, S.; Zacharakis, E.; Mohr, F.; Athanasiou, T.; Darzi, A.; Ziprin, P. Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: A meta-analysis. Ann. Surg. Oncol. 2008, 15, 60-68.
41. Knudsen, P.J. The peritoneal elastic lamina. J. Anat. 1991, 177, 41-46.
42. Shinto, E.; Ueno, H.; Hashiguchi, Y.; Hase, K.; Tsuda, H.; Matsubara, O.; Mochizuki, H. The subserosal elastic lamina: An anatomic landmark for stratifying pT3 colorectal cancer. Dis. Colon Rectum 2004, 47, 467-473.
43. Kojima, M.; Nakajima, K.; Ishii, G.; Saito, N.; Ochiai, A. Peritoneal elastic laminal invasion of colorectal cancer. The diagnostic utility and clinicopathologic relationship. Am. J. Surg. Pathol. 2010, 34, 1351-1360.
44. Stewart, C.J.R.; Brennan, B.A.; Crook, M.; Russell, P. Value of elastin staining in the assessment of peritoneal implants associated with ovarian serous borderline tumours. Histopathology 2007, 51, 313-321.
45. Vass, D.G.; Ainsworth, R.; Anderson, J.H.; Murray, D.; Foulis, A.K. The value of an elastic tissue stain in detecting venous invasion in colorectal cancer. J. Clin. Pathol. 2004, 57, 769-772.
46. Howlett, C.J.; Tweedie, E.J.; Driman, D.K. Use of elastic stain to show venous invasion in colorectal carcinoma: A simple technique for detection of an important prognostic factor. J. Clin. Pathol. 2009, 62, 1021-1025.
47. Puppa, G.; Caneva, A.; Colombari, R. Venous invasion detection in colorectal cancer: Which approach, which technique? J. Clin. Pathol. 2009, 62, 102-103.
48. Roxburgh, C.S.D.; McMillan, D.C.; Anderson, J.H.; McKee, R.F.; Horgan, P.G.; Foulis, A.K. Elastica staining for venous invasion results in superior prediction of cancer-specific survival in colorectal cancer. Ann. Surg. 2010, 252, 989-997.
49. Williams, G.T.; Quirke, P.; Shepherd, N.A. Dataset for colorectal cancer, 2nd ed.; The Royal College of Pathologists: London, UK, 2007.
50. Wittekind, C., Greene, F.L., Henson, D.E., Hutter, R.V.P., Sobin, L.H. A Commentary on Uniform Use. In TNM Supplement, 3rd ed.; Wiley-Liss: New York, NY, USA, 2003; pp. 142-143.
51. Keshava, A.; Chapuis, P.H.; Chan, C.; Lin, B.P.C.; Bokey, E.L.; Dent, O.F. The significance of involvement of a free serosal surface for recurrence and survival following resection of clinicopathological stage B and C rectal cancer. Colorectal Dis. 2007, 9, 609-618.
52. Stewart, C.J.R.; Hillery, S.; Platell, C. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch. Pathol. Lab. Med. 2009, 133, 1359-1360.
53. Puppa, G.; Caneva, A.; Colombari, R.; Sonzogni, A.; Pelosi, G. For the sake of clarity about pT4 category of colorectal cancer. Arch. Pathol. Lab. Med. 2009, 133, 340.
54. Jessup, J.M.; Compton, C.C.; Washington, M.K. For the sake of clarity about pT4 category of colorectal cancer. Arch. Pathol. Lab. Med. 2009, 133, 340-341.
55. Gunderson, L.L.; Jessup, J.M.; Sargent, D.J.; Greene, F.L.; Stewart, A.K. Revised TN categorization for colon cancer based on national survival outcomes data. J. Clin. Oncol. 2010, 28, 264-271.
56. Gunderson, L.L.; Jessup, J.M.; Sargent, D.J.; Greene, F.L.; Stewart, A.K. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J. Clin. Oncol. 2010, 28, 256-263.
57. Nagtegaal, I.D.; Quirke, P. Revised staging: Is it really better, or do we not know. J. Clin. Oncol. 2010, 28, e397-e398.
58. Morris, E.J.A.; Maughan, N.J.; Forman, D.; Quirke, P. Who to treat with adjuvant therapy in Dukes' B/ stage II colorectal cancer? The need for high quality pathology. Gut 2007, 56, 1419-1425.
59. Chan, N.G.; Duggal, A.; Weir, M.M.; Driman, D.K. Pathological reporting of colorectal cancer specimens: A retrospective survey in an academic Canadian pathology department. Can. J. Surg. 2008, 51, 284-288.
60. Quirke, P.; Morris, E. Reporting colorectal cancer. Histopathology 2007, 50, 103-112.
61. Darakhshan, A.; Lin, B.P.F.C.; Chan, C.; Chapuis, P.H.; Dent, O.F.; Bokey, L. Correlates and outcomes of tumor adherence in resected colonic and rectal cancers. Ann. Surg. 2008, 247, 650-658.
62. Mori, T. A comparison of the new (planned) TNM classification and Japanese general rule for staging colorectal cancer. Cancer Invest. 2010, 28, 387-392.
63. Quirke, P.; Williams, G.T.; Ectors, N.; Ensari, A.; Piard, F.; Nagtegaal, I. The future of the TNM staging system in colorectal cancer: Time for a debate? Lancet Oncol. 2007, 8, 651-657.
64. Quirke, P.; Cuvelier, C.; Ensari, A.; Glimelius, B.; Laurberg, S.; Ortiz, H.; Piard, F.; Punt, C.J.A.; Glenthoj, A.; Pennickx, F.; et al. Evidence-based medicine: The time has come to set standards for staging. J. Pathol. 2010, 221, 357-360.